Dublin, Ireland

Conor B Mc Crystal



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Conor B Mc Crystal: Innovator in Pharmaceutical Composition

Introduction

Conor B Mc Crystal is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the delivery of bioactive materials. His innovative approach has led to the development of a unique solid pharmaceutical composition.

Latest Patents

Conor holds a patent for the "Delivery of a bioactive material." This patent describes a solid pharmaceutical composition that includes a water-soluble bioactive material and an encapsulating material. The encapsulating material is present in a continuous solid phase, with solid particles of the bioactive material dispersed within it. The bioactive material is preferably a bisphosphonate, most notably alendronate. The encapsulating material may include enhancers such as mono- or di-glycerides or surfactants like polyoxyethylene/polyoxypropylene block copolymers. The process for preparing this composition involves mixing solid particles of the bioactive material with the molten encapsulating material and then cooling it to form a solid composition.

Career Highlights

Conor B Mc Crystal is associated with Merrion Research III Limited, where he continues to advance his research and development efforts. His work focuses on improving pharmaceutical formulations to enhance the delivery and efficacy of bioactive compounds.

Collaborations

Conor collaborates with esteemed colleagues, including Maurice Joseph Anthony Clancy and K Iain Cumming. Their combined expertise contributes to the innovative projects at Merrion Research III Limited.

Conclusion

Conor B Mc Crystal is a prominent figure in the pharmaceutical industry, recognized for his innovative patent in the delivery of bioactive materials. His contributions are paving the way for advancements in drug formulation and delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…